HCAT
Health Catalyst, Inc.$1.63 −0.06 (−3.25%)
Oct 26 4:00 PM ET · prev $1.69
Market cap
$130.9M
Micro cap
Consensus
Buy
55% Buy or better · 11 analysts
Median target
$1.80
+10% · range $1.50–2.00
Next earnings
Nov 5
in 10 days · EPS est. −$0.05
1 year
−52.7%
from $3.46 · Oct 27
30 days
−7.6%
from $1.77
52-week range
$0.9960–3.46
−53% from high · low Apr 10
Avg volume 20D
363.3K
Oct 13 spike 1.27M
Short interest
2.21M
≈2.9% of shares · +9.1%
Days to cover
5.2
at average volume
Insider net
+$105.4K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 4 reports · 90 days
Balance 0 bearish · 0 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 3/4 ·Next Earnings date, Nov 5, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- R Apr 27 Health Catalyst announced a 9% workforce reduction and elimination o…
- R May 11 Health Catalyst reported Q1 2026 revenue of $70.8M, down 11% YoY, wi…
- R Jun 4 Health Catalyst signed a definitive agreement to sell its Vitalware…
- A Aug 21 Canaccord Genuity downgrades
- B Sep 14 1 insider buy $105.4K at $1.79
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $105.4K at an average $1.79. No open-market sales. Price is 9% below their cost.
- InstitutionsBEARISH
Q2 2026: 15 added (0 new), 23 trimmed or exited.
- AnalystsBULLISH
6 of 11 rate it Buy or better. Median target $1.80 (+10%).
- EstimatesFALLING
Current-quarter EPS estimate −$0.000 → −$0.048 over 90 days. 0 up, 3 down in 30 days.
- Short sellersSTEADY
Short interest +9.1% to 2.21M shares. 5.2 days to cover, ≈2.9% of shares.
- TrendDOWNTREND
5% below its 50-day average.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| Impax Asset Management Group plc | ADD | $8.0M |
| BlackRock, Inc. | TRIM | $3.7M |
| JANE STREET GROUP, LLC | DOUBLED | $2.1M |
| DIMENSIONAL FUND ADVISORS LP | TRIM | $1.8M |
| GEODE CAPITAL MANAGEMENT, LLC | TRIM | $1.8M |
| HRT FINANCIAL LP | DOUBLED | $1.1M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | DOUBLED | $870.1K |
| HSBC HOLDINGS PLC | DOUBLED | $809.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
11 analysts 55% rate it Buy or better
12-month targets · 3 analysts
$1.63 $1.50 $1.80 $2.00
Price is inside the target range. Median implies +10%.Targets as of Oct 26, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Aug 21, 2026 | Canaccord Genuity DOWNGRADE | Hold |
| Aug 13, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Aug 11, 2026 | Citigroup MAINTAIN | Neutral |
| Jul 21, 2026 | Canaccord Genuity MAINTAIN | Buy |
| Jun 26, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| May 12, 2026 | Stephens & Co. MAINTAIN | Equal-Weight |
Insider ledger
Form 4$105.4K
bought · 1 insider
$0
sold · 0 insiders
−8.5%
vs their $1.79 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 1, 2026 | Reller Tami Director | AWARD | 128,851 sh |
| Sep 14, 2026 | Kohl Simeon Chief Executive Officer | AWARD | 2,747,385 sh |
| Sep 14, 2026 | Kohl Simeon Chief Executive Officer | BUY | $105.4K |
| Sep 10, 2026 | Albert Benjamin CEO | TAX W/H | $59.0K |
| Sep 1, 2026 | Landry Benjamin General Counsel | TAX W/H | $22.4K |
| Sep 1, 2026 | Albert Benjamin CEO | TAX W/H | $546.86 |
| Sep 1, 2026 | Larson-Green Julie Director | AWARD | 9,766 sh |
| Sep 1, 2026 | Alger Jason Chief Financial Officer | TAX W/H | $30.6K |
Earnings setup
EstimatesNov 5
reports in 10 days
−$0.05
EPS estimate, this quarter
−10947%
estimate change, 90 days
0↑ 3↓
revisions, 30 days
Current-quarter EPS estimate
−$0.00090d
−$0.00060d
−$0.05430d
−$0.0547d
−$0.048Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.05 | -$0.07–-$0.02 | +11.4% | $55.4M |
| Next Q | -$0.04 | -$0.06–-$0.03 | +8.0% | $51.2M |
| Current FY | -$0.04 | -$0.07–$0.00 | +22.8% | $247.8M |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Sep 30, 20262,212,809
shares short
+9.1%
vs prior settlement
5.2
days to cover
≈2.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Health Catalyst, Inc. announced it will report its Q3 2026 results on November 5, 2026.
PRESS-RELEASE — Impact 1/10
Oct 22, 2026 Earnings
Oct 5, 2026 SEC Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (
Tamra Reller filed a Form 3 initial statement of beneficial ownership with Health Catalyst, Inc. (HCAT) on October 5…
3 — Impact 2/10
Oct 1, 2026 Insider
Sep 14, 2026 SEC Reller Tami was granted 128,851 shares
Director
Health Catalyst appointed Tami Reller to its board of directors, effective October 1, 2026, expanding the board from…
8-K — Impact 3/10
Sep 14, 2026 Insider
Kohl Simeon was granted 2,747,385 shares
Chief Executive Officer
Sep 14, 2026 Insider
Kohl Simeon bought 59,000 shares
Chief Executive Officer @ $1.79 ($105.4K)
Jul 29, 2026 Event
HSR Early Termination: HP Prestige Aggregator, LP; Health Catalyst, Inc.
The FTC granted early termination of the HSR Act waiting period for a transaction involving HP Prest
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 22, 2026
Earnings
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (
Sep 14, 2026
Press release
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare…
Aug 31, 2026
Press release
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company…
Aug 14, 2026
Short interest
Short Interest: HCAT down 23% to 2.3M shares
Settlement 2026-08-14 | Days to cover: 1.64 | ≈3.04% of shares outstanding (est.)
Aug 6, 2026
Earnings date
HCAT Q2 2026 Earnings Scheduled — 2026-08-06
SecBot reports
10 filings · 1 press release · 1 bullish · 2 bearish · 7 neutral- NEUTRAL PRESS-RELEASEOct 22, 2026
Health Catalyst, Inc. announced it will report its Q3 2026 results on November 5, 2026.
- NEUTRAL 3Oct 5, 2026
Tamra Reller filed a Form 3 initial statement of beneficial ownership with Health Catalyst, Inc…
This is a standard new-reporting-person Form 3 with no trading activity or change in company operations. No actionable signal for traders.
- NEUTRAL 8-KSep 14, 2026
Health Catalyst appointed Tami Reller to its board of directors, effective October 1, 2026…
This is a routine board appointment with no immediate financial impact. Monitor for any strategic shifts under new CEO Simeon Kohl, but this filing alone does not warrant a trading response.
- NEUTRAL PRESS-RELEASEJul 28, 2026
Health Catalyst, Inc. announced it will report its Q2 2026 results on August 6, 2026.
All HCAT filing & press-release reports (11)
- PRESS-RELEASE reportOct 22, 2026
- 3 reportOct 5, 2026
- 8-K reportSep 14, 2026
- PRESS-RELEASE reportJul 28, 2026
- 8-K reportJun 4, 2026
- DEFA14A reportJun 3, 2026
- 8-K reportMay 11, 2026
- PRESS-RELEASE reportMay 1, 2026
- 10-K/A reportApr 30, 2026
- PRESS-RELEASE reportApr 30, 2026
- 8-K reportApr 27, 2026